Richard A. Westhouse
Bristol-Myers Squibb (Sweden)(SE)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Pharmacogenetics and Drug Metabolism, Cancer, Hypoxia, and Metabolism, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor(2005)203 cited
- → Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK)(2019)106 cited
- → Respiratory and Pharyngo-Esophageal Iridovirus Infection in a Gopher Tortoise (Gopherus polyphemus)(1996)89 cited
- → Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors(2015)88 cited
- → A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokines(2017)67 cited
- → Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design(2021)42 cited
- → Cytochrome P450 11A1 Bioactivation of a Kinase Inhibitor in Rats: Use of Radioprofiling, Modulation of Metabolism, and Adrenocortical Cell Lines to Evaluate Adrenal Toxicity(2012)27 cited
- → Safety Assessment Considerations and Strategies for Targeted Small Molecule Cancer Therapeutics in Drug Discovery(2009)21 cited
- → Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer(2018)16 cited
- → A Bioanalytical Strategy Utilizing Dried Blood Spot Sampling And Lc–MS/MS in Discovery Toxicology Studies(2012)13 cited